[Pharmakokinetics of Hydroxy-urea. Therapy of Acute Myeoblastic Leukemias Using Synchronization and Recruitment Effects (author' Transl)]
Overview
Authors
Affiliations
By a plasma-concentration of hydroxy-urea (HU) higher than 0.5-2.2x10(-4)M the DNA-synthesis in leukemia cells was blocked reversibly in 9 patients. The plasma half-time of HU varied between 120 and 198 min. To synchronize leukemic cell populations the DNS-synthesis was blocked over a period of 36 hours by maintaining the HU-concentration above the critical lower level. In a second phase-specific therapeutic step cytosine-arabinoside (AraC) was given 4 times in a dose of 1 mg/kg each. A recruitment after the application of AarC made more cells available for the next following synchronization step. 4 acute myeloblastic leukemias with high peripheral cell counts were treated according to this schedule. One patient is still in complete remission for now 14 month. This synchronization/recruitment schedule seems to be successful in acute myeloblastic leukemias with high proliferation rates measured by biochemical and cytokinetic methods.
Rudd S, Tsesmetzis N, Sanjiv K, Paulin C, Sandhow L, Kutzner J EMBO Mol Med. 2020; 12(3):e10419.
PMID: 31950591 PMC: 7059017. DOI: 10.15252/emmm.201910419.
Camplejohn R, Schultze B, Maurer W Br J Cancer. 1977; 35(5):546-56.
PMID: 861145 PMC: 2025495. DOI: 10.1038/bjc.1977.88.
Sauer H, Wilmanns W Klin Wochenschr. 1976; 54(5):197-202.
PMID: 768630 DOI: 10.1007/BF01469125.
[Influence of hydroxyurea on DNA synthesis of human bone marrow in vivo (author's transl)].
Hartenstein R, ERTL E, Possinger K, EHRHART H Klin Wochenschr. 1979; 57(21):1191-3.
PMID: 513612 DOI: 10.1007/BF01491760.
[Partial synchronization of tumor cells in vivo with hydroxyurea (author's transl)].
Hartenstein R, Pfundmair K, Possinger K Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977; 88(3):261-72.
PMID: 140543 DOI: 10.1007/BF00305364.